Coldstream Capital Management Inc Viridian Therapeutics, Inc.\De Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VRDN
# of Institutions
200Shares Held
79.8MCall Options Held
419KPut Options Held
686K-
Deep Track Capital, LP Greenwich, CT5.38MShares$69.4 Million2.54% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$61.6 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.7MShares$60.6 Million5.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.56MShares$58.9 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$50.1 Million12.28% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $515M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...